Cargando…

A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice

INTRODUCTION: The pathogenic mechanisms of diabetic nephropathy (DN) include podocyte injury, inflammatory responses and metabolic disorders. Although the antagonism of Angiopoietin-like protein 3 (ANGPTL3) can alleviate proteinuria symptoms by inhibiting the activation of integrin αvβ3 on the surfa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Qianqian, Hu, Xiaozhi, Liu, Fangyu, Cao, Zhonglian, Han, Lei, Zhou, Kaicheng, Bai, Yu, Zhang, Yuting, Nan, Yanyang, Lv, Qianying, Rao, Jia, Wu, Tao, Yang, Xue, He, Haidong, Ju, Dianwen, Xu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760875/ https://www.ncbi.nlm.nih.gov/pubmed/36544775 http://dx.doi.org/10.3389/fimmu.2022.1011442

Ejemplares similares

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
por: Shen, Yilan, et al.
Publicado: (2021)

Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases
por: Ma, Qianqian, et al.
Publicado: (2022)

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
por: Wang, Shaofei, et al.
Publicado: (2017)

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage
por: Lv, Qianying, et al.
Publicado: (2022)

Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis
por: Zhang, Yuting, et al.
Publicado: (2023)

A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease
por: Hu, Xiaozhi, et al.
Publicado: (2022)

Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response
por: Cao, Zhonglian, et al.
Publicado: (2023)

ANGPTL4: A Predictive Marker for Diabetic Nephropathy
por: Al Shawaf, Eman, et al.
Publicado: (2019)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury
por: Chen, Wei, et al.
Publicado: (2017)

The Study of Angptl4-Modulated Podocyte Injury in IgA Nephropathy
por: Jia, Sha, et al.
Publicado: (2021)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
por: Fang, Si, et al.
Publicado: (2022)

Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
por: Xue, Lingyu, et al.
Publicado: (2017)

Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”
por: Zhang, Feifei, et al.
Publicado: (2023)

Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022)

Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy
por: AlMajed, Hana Th., et al.
Publicado: (2023)

ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
por: Chi, Xun, et al.
Publicado: (2017)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Interleukin-22 Ameliorates Cerulein-Induced Pancreatitis in Mice by Inhibiting the Autophagic Pathway
por: Feng, Dechun, et al.
Publicado: (2012)

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
por: Biterova, Ekaterina, et al.
Publicado: (2018)

Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
por: Sun, Ting, et al.
Publicado: (2021)

TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus Through SREBP-1/ANGPTL8 Pathway
por: Wu, Xiaozhi, et al.
Publicado: (2023)

ANGPTL3 as therapeutic target
por: Kersten, Sander
Publicado: (2021)

Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D
por: Abu-Farha, Mohamed, et al.
Publicado: (2016)

Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension
por: Abu-Farha, Mohamed, et al.
Publicado: (2018)

Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment
por: Valiakou, Vaia, et al.
Publicado: (2021)

Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22
por: Kim, Suhyun, et al.
Publicado: (2022)

Variable Changes of Circulating ANGPTL3 and ANGPTL4 in Different Obese Phenotypes: Relationship with Vasodilator Dysfunction
por: Schinzari, Francesca, et al.
Publicado: (2021)

Angptl2 is a Marker of Cellular Senescence: The Physiological and Pathophysiological Impact of Angptl2-Related Senescence
por: Thorin-Trescases, Nathalie, et al.
Publicado: (2021)

Recombinant betatrophin (Angptl-8/lipasin) ameliorates streptozotocin-induced hyperglycemia and β-cell destruction in neonatal rats
por: Zhang, Di, et al.
Publicado: (2019)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Fukami, Hirotaka, et al.
Publicado: (2021)

Dual role of ANGPTL4 in inflammation
por: Zuo, Yuyue, et al.
Publicado: (2023)

Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin
por: Hu, Bang-li, et al.
Publicado: (2016)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
por: Chen, Yan Q., et al.
Publicado: (2020)

Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
por: Chen, Wei, et al.
Publicado: (2020)

Fasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism
por: Dang, Fabin, et al.
Publicado: (2016)

Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
por: Ji, Baowei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_255fm2es2h7valq8t3skhhrlfd